Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors

195Citations
Citations of this article
149Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The expression levels of the p21Cip1 family CDK inhibitors (CKIs), p21Cip1, p27Kip1 and p57Kip2, play a pivotal role in the precise regulation of cyclin-dependent kinase (CDK) activity, which is instrumental to proper cell cycle progression. The stabilities of p21Cip1, p27Kip1 and p57Kip2 are all tightly and differentially regulated by ubiquitylation and proteasome-mediated degradation during various stages of the cell cycle, either in steady state or in response to extracellular stimuli, which often elicit site-specific phosphorylation of CKIs triggering their degradation. © 2010 Landes Bioscience.

Cite

CITATION STYLE

APA

Lu, Z., & Hunter, T. (2010, June 15). Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.9.12.11988

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free